Susan Jean Wallcraft
Director/Board Member at Amnesty International Charity Ltd.
Susan Jean Wallcraft active positions
| Companies | Position | Start | End |
|---|---|---|---|
Amnesty International Charity Ltd.
 Amnesty International Charity Ltd. Miscellaneous Commercial ServicesCommercial Services Amnesty International Charity Ltd. was founded in 1986 and promotes and protects human rights. The non-profit company is based in London, UK. | Director/Board Member | 27/05/2017 | - |
Career history of Susan Jean Wallcraft
Former positions of Susan Jean Wallcraft
| Companies | Position | Start | End |
|---|---|---|---|
| VERNALIS | Corporate Secretary | 24/01/2018 | 30/03/2019 |
Pfizer Consumer Healthcare (United Kingdom)
 Pfizer Consumer Healthcare (United Kingdom) Drugstore ChainsRetail Trade Pfizer Consumer Healthcare Ltd. wholesales pharmaceutical goods. The company was established in 1913 and is headquartered in Berks, GB. | Director/Board Member | 03/03/2011 | 05/04/2011 |
Statistics
International
| United Kingdom | 4 |
Operational
| Director/Board Member | 2 |
| Corporate Secretary | 1 |
Sectoral
| Retail Trade | 2 |
| Commercial Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Pfizer Consumer Healthcare (United Kingdom)
Pfizer Consumer Healthcare (United Kingdom) Drugstore ChainsRetail Trade Pfizer Consumer Healthcare Ltd. wholesales pharmaceutical goods. The company was established in 1913 and is headquartered in Berks, GB. | Retail Trade |
Amnesty International Charity Ltd.
Amnesty International Charity Ltd. Miscellaneous Commercial ServicesCommercial Services Amnesty International Charity Ltd. was founded in 1986 and promotes and protects human rights. The non-profit company is based in London, UK. | Commercial Services |
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Susan Jean Wallcraft
- Experience
